Key result
High myocardial 99mTc-octreotide accumulation is linked to ~10-point lower LVEF.
Why the study?
To evaluate the relationship between the clinical course of MI, changes in LV geometry, and myocardial accumulation of the somatostatin analogue 99mTc-octreotide detected by cardiac SPECT.
Does high myocardial accumulation of 99mTc-octreotide correlate with adverse left ventricular remodeling in patients with anterior STEMI?
Cohort (n=14)
No
Does high myocardial accumulation of 99mTc-octreotide correlate with adverse left ventricular remodeling in patients with anterior STEMI?
Intense myocardial accumulation of 99mTc-octreotide corresponds to local post-infarction inflammation and correlates with early adverse left ventricular remodeling after anterior STEMI.
Answers are grounded in this paper and cite their sources.
High 99mTc-octreotide uptake may flag greater early remodeling risk after anterior STEMI; leaves open added prognostic value beyond echocardiography.
Aim. To study the relationship between the clinical course of myocardial infarction (MI) with changes in left ventricular (LV) geometry and myocardial accumulation of the somatostatin analogue 99mTc-octreotide according to cardiac single-photon emission computed tomography (SPECT). Material and methods. This pilot, cohort, prospective study included 14 patients aged 37 to 72 years with primary anterior ST-segment elevation MI. Patients underwent a general clinical examination, 3-fold determination of high-sensitivity C-reactive protein (hsCRP), echocardiography on days 1-3, cardiac SPECT with 99mTc-octreotide on days 6-7 from MI onset. Statistical analysis was performed using STATISTICA 10.0, StatSoft, USA. Results. In 10 of 14 patients, 99mTc-octreotide accumulation in LV involvement area was recorded. The accumulation analysis showed varying intensity. This made it possible to form two subgroups with high and low accumulation of 99mTc-octreotide (heart-to-cavity LV ratio more and less than 1,5, respectively). Clinical characteristics and MI course, length of hospital stay did not differ between the subgroups. Occlusion of the infarct-related coronary artery (in 5 (62,5%) vs 0 (0%) patients, p=0,016) was more common in the group with increased versus decreased accumulation of 99mTc-octreotide, respectively. Laboratory analysis showed a significant increase in hsCRP upon admission in patients with increased vs decreased accumulation of 99mTc-octreotide — 31,6 mg/l (10,45-42,05) vs 6,5 mg/l (3,2-11,8), p=0,043, respectively. A significant increase in end-diastolic and end-systolic LV volumes was established. There were an increase in LV sphericity index and local contractility disruption index along with a decrease in LV ejection fraction in the subgroup with high vs reduced accumulation of 99mTc-octreotide (47,5% (45,5-51,5) vs 57,5% (54-59), p=0,020) in the damage zone, respectively. In addition, a predictive relationship between the increase in LV end-diastolic volume and the severity of 99mTc-octreotide accumulation was found (R 2 =0,601, F-ratio=16,562, p=0,002). Conclusion. An increase in hsCRP and early initiation of LV remodeling after primary anterior ST-segment elevation MI is accompanied by a pronounced accumulation of 99mTc-octreotide in the damage zone, detected using cardiac SPECT, as a result of systemic and local, in our opinion, macrophage-mediated post-infarction inflammation.
No takes yet. Share an insight, caveat, or question.
Ryabov et al. (2023) conducted a cohort in Primary anterior ST-segment elevation myocardial infarction (STEMI) (n=14). High myocardial accumulation of 99mTc-octreotide vs. Low myocardial accumulation of 99mTc-octreotide was evaluated on Left ventricular ejection fraction in the damage zone (p=0.020). High myocardial accumulation of 99mTc-octreotide was associated with a significantly lower left ventricular ejection fraction compared to low accumulation (47.5% vs 57.5%, p=0.020).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: